Induced membrane maintains its osteogenic properties even when the second stage of Masquelet's technique is performed later.


Journal

European journal of trauma and emergency surgery : official publication of the European Trauma Society
ISSN: 1863-9941
Titre abrégé: Eur J Trauma Emerg Surg
Pays: Germany
ID NLM: 101313350

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 23 10 2018
accepted: 08 07 2019
pubmed: 20 7 2019
medline: 4 2 2021
entrez: 20 7 2019
Statut: ppublish

Résumé

Previous clinical studies have shown the effectiveness of bone repair using two-stage surgery called the induced membrane (IM) technique. The optimal wait before the second surgery is said to be 1 month. We have been successfully performing the IM technique while waiting an average of 6 months to carry out the second stage. We hypothesised that the IM maintains its beneficial capabilities, even at a later second stage, and that there is no relation between the speed of bone union and the wait between the first and second stage. We sought to explore the biological properties of 'older' IMs sampled to substantiate our clinical observations. Thirty-four patients with a critical size defect were treated with the IM technique. In seven of these patients, pieces of the IM were collected 4.2-14.7 months after the first surgery. IM-derived cell phenotype and osteogenic potential were investigated using in vitro studies (n = 4) while IM nature and function were investigated by histology and immunohistochemistry (n = 3). The median wait before the second surgery was 5.8 months [range 1.2-14.7] and bone healing occurred at 7.6 months [range 2.5-49.9] for 26 patients. IMs aged 4.2-14.7 months contained mesenchymal stromal cells with in vitro osteogenic potential and corresponded to a multipotent tissue with osteogenic and chondrogenic capabilities contributing to osteogenesis over time. This preliminary study suggests the IM retains its powerful osteogenic properties over time and that waiting longer between the two surgeries does not delay bone union.

Identifiants

pubmed: 31321472
doi: 10.1007/s00068-019-01184-4
pii: 10.1007/s00068-019-01184-4
doi:

Substances chimiques

Bone Cements 0
Polymethyl Methacrylate 9011-14-7

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

301-312

Commentaires et corrections

Type : ErratumIn

Références

Ann Chir Plast Esthet. 2000 Jun;45(3):346-53
pubmed: 10929461
Injury. 2016 Dec;47 Suppl 6:S68-S76
pubmed: 28040090
Regen Med. 2018 Jun;13(4):477-490
pubmed: 29985779
Eur Cell Mater. 2012 Jan 12;23:13-27
pubmed: 22241610
J Tissue Eng Regen Med. 2017 Feb;11(2):382-389
pubmed: 24919776
J Orthop Trauma. 2015 Dec;29(12):554-7
pubmed: 25875174
Orthop Traumatol Surg Res. 2013 Dec;99(8):959-64
pubmed: 24211125
Rev Stomatol Chir Maxillofac. 2012 Sep;113(4):231-8
pubmed: 22840565
Indian J Orthop. 2016 May-Jun;50(3):290-6
pubmed: 27293290
Chir Main. 2011 Sep;30(4):255-63
pubmed: 21816650
Bone Joint Res. 2016 Apr;5(4):106-15
pubmed: 27056768
J Pediatr Orthop. 2011 Jul-Aug;31(5):570-6
pubmed: 21654468
Bone. 2013 Dec;57(2):484-92
pubmed: 23954755
J Orthop Trauma. 2017 Oct;31 Suppl 5:S36-S38
pubmed: 28938390
Injury. 2016 Oct;47(10):2051-2052
pubmed: 27697199
J Orthop Trauma. 2016 Jun;30(6):e188-93
pubmed: 26618666
J Bone Joint Surg Am. 2013 Apr 3;95(7):597-604
pubmed: 23553294
Cytotherapy. 2006;8(4):315-7
pubmed: 16923606
Chir Main. 2010 Dec;29 Suppl 1:S221-4
pubmed: 21084208
Chir Main. 2010 Oct;29(5):307-14
pubmed: 20728395
Orthopedics. 2014 Nov;37(11):e1045-8
pubmed: 25361369
Science. 1999 Apr 2;284(5411):143-7
pubmed: 10102814
Injury. 2011 Jun;42(6):591-8
pubmed: 21543068
Orthop Traumatol Surg Res. 2016 Feb;102(1 Suppl):S133-9
pubmed: 26774902
ScientificWorldJournal. 2014 Feb 06;2014:710302
pubmed: 24688420
Ann Biomed Eng. 2019 Jan;47(1):174-189
pubmed: 30259220
Injury. 2015 Dec;46 Suppl 8:S44-7
pubmed: 26747918
J Orthop Trauma. 2016 Oct;30(10):545-550
pubmed: 27124824
Hand Surg Rehabil. 2016 Apr;35(2):114-21
pubmed: 27117125
J Cell Biol. 1981 Mar;88(3):630-6
pubmed: 7217207
J Bone Miner Res. 1999 Jul;14(7):1115-22
pubmed: 10404011
Tissue Eng Part A. 2017 Feb;23(3-4):91-100
pubmed: 27998243
Blood. 2008 Mar 1;111(5):2631-5
pubmed: 18086871
J Tissue Eng Regen Med. 2016 Oct;10(10):E382-E396
pubmed: 24668794

Auteurs

Florelle Gindraux (F)

Orthopaedic and Traumatology Surgery Department, University Hospital of Besancon, Besancon, France. fgindraux@chu-besancon.fr.
Nanomedicine Lab, Imagery and Therapeutics (EA 4662), SFR FED 4234, University of Franche-Comté, Besancon, France. fgindraux@chu-besancon.fr.

François Loisel (F)

Orthopaedic and Traumatology Surgery Department, University Hospital of Besancon, Besancon, France.
Nanomedicine Lab, Imagery and Therapeutics (EA 4662), SFR FED 4234, University of Franche-Comté, Besancon, France.

Michael Bourgeois (M)

Orthopaedic and Traumatology Surgery Department, University Hospital of Besancon, Besancon, France.

Karim Oudina (K)

Laboratory of Bioengineering and Biomechanics for Bone Articulation (B2OA-UMR CNRS 7052), University Paris Diderot, Paris, France.

Martine Melin (M)

Novotec, Bron, France.

Benoit de Billy (B)

Nanomedicine Lab, Imagery and Therapeutics (EA 4662), SFR FED 4234, University of Franche-Comté, Besancon, France.
Paediatric Surgery Department, University Hospital of Besancon, Besancon, France.

Pauline Sergent (P)

Orthopaedic and Traumatology Surgery Department, University Hospital of Besancon, Besancon, France.

Gregoire Leclerc (G)

Orthopaedic and Traumatology Surgery Department, University Hospital of Besancon, Besancon, France.

Hervé Petite (H)

Laboratory of Bioengineering and Biomechanics for Bone Articulation (B2OA-UMR CNRS 7052), University Paris Diderot, Paris, France.

Frederic Auber (F)

Nanomedicine Lab, Imagery and Therapeutics (EA 4662), SFR FED 4234, University of Franche-Comté, Besancon, France.
Paediatric Surgery Department, University Hospital of Besancon, Besancon, France.

Laurent Obert (L)

Orthopaedic and Traumatology Surgery Department, University Hospital of Besancon, Besancon, France.
Nanomedicine Lab, Imagery and Therapeutics (EA 4662), SFR FED 4234, University of Franche-Comté, Besancon, France.

Isabelle Pluvy (I)

Orthopaedic and Traumatology Surgery Department, University Hospital of Besancon, Besancon, France.
Nanomedicine Lab, Imagery and Therapeutics (EA 4662), SFR FED 4234, University of Franche-Comté, Besancon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH